+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Advanced Medical Stopcock Market to 2027 - Regional Analysis and Forecasts by Type, and End User, and Country

  • ID: 4825275
  • Report
  • Region: Europe
  • 112 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2020
1 of 3
The Europe advanced medical stopcock market is expected to reach US$ 321.6 Mn in 2027 from US$ 237.2 Mn in 2018. The market is projected to grow with a CAGR of 3.6% from 2019-2027.

Increasing geriatric population, rising prevalence lung cancer, consumption of the alcohol and tobacco, illegal drugs are fostering the growth of the intravenous and infusion therapies which in return resulting into the higher demand for medical stopcocks. However, the market is likely to get impacted by the risk factor such as safety concerns for using stopcocks during the forecast period.

Alzheimer disease and dementia, asthma, cancer, COPD, cystic fibrosis, diabetes, heart diseases are few of the leading chronic diseases that may cause death in individuals. The practice such as use of tobacco, alcohol consumption, poor nutrition and lack of physical activity among others are the leading factors for the chronic diseases. Therefore, the cases of chronic diseases is increasing these days. For instance, In Germany the risk of the chronic obstructive pulmonary disease (COPD) has a high prevalence rate and is expected to increase in the coming days. The leading cause of death in Germany is COPD; thus it is listed in the high disease burden. As per a report published in 2018, stated that approximately 12% of the older adults in Germany suffer from COPD. In 2016, nearly 7 million were registered with COPD in the country, and it is estimated that the number will increase to 8 million by 2030. According to the World Health Organization (WHO), it is estimated that COPD is expected to be the third most often cause of death by 2030.

In 2018, Europe advanced medical stopcock market held a market share of 28.20% of the global advanced medical stopcock market. The low-pressure stopcocks segment expected to dominate its market share and was valued at US$ 129.3 Mn in 2018 and is anticipated to reach US$ 180.0 Mn by 2027. . On the other hand, low-pressure stopcocks segment is also anticipated to witness the fastest growth rate of 4.0% during the forecast period, 2019 to 2027.

Similarly, in 2018 medium-pressure stopcocks segment was valued at US$ 65.8 Mn in 2018 and is anticipated to reach US$ 82.8 Mn by 2027 and is also expected to grow at the fastest growth rate of 3.2 % during the forecast period.

Furthermore, the hospitals & clinics segment held a largest market share of 41.9% of the advanced medical stopcock market, in 2018. This segment is also expected to dominate the market in 2027 as it is the primary care center for most of the population.

Some of the major primary and secondary sources for advanced medical stopcock included in the report are, Cancer Organisation Soutein, Centers for European Heart Network (EHN), Central and Eastern Europe’s (CEE’s), European Commission, and etc.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Scope Of The Study
1.2 Research Report Guidance

2. Europe Advanced Medical Stopcock Market – Key Takeaways

3. Europe Advanced Medical Stopcock Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Advanced Medical Stopcock Market – By Type
3.2.2 Europe Advanced Medical Stopcock Market – By End User
3.2.3 Europe Advanced Medical Stopcock Market – By Europe Region
3.3 Pest Analysis
3.4 Key Market Drivers
3.4.1 Increasing Prevalence Of Chronic Diseases
3.4.2 Surgical Procedures Are Increasing
3.5 Key Market Challenge
3.5.1 Protection While Using Stopcocks
3.6 Key Market Opportunities
3.6.1 Emerging Economics
3.7 Impact Analysis

4. Advanced Medical Stopcock Market – Europe Analysis
4.1 Europe Advanced Medical Stopcock Market Revenue Forecasts And Analysis
4.2 Performance Of Key Players
4.2.1 Utah Medical Products Inc.
4.2.2 Nipro

5. Advanced Medical Stopcock Market Analysis And Forecasts To 2027 – Type
5.1 Overview
5.2 Europe Advanced Medical Stopcock Market Share By Type 2018 & 2027 (%)
5.3 Low-Pressure Stopcocks Market
5.3.1 Overview
5.3.2 Low-Pressure Stopcocks Market Revenue and Forecast to 2027 (US$ Mn)
5.4 Medium-Pressure Stopcocks Market
5.4.1 Overview
5.4.2 Medium-Pressure Stopcocks Market Revenue and Forecast to 2027 (US$ Mn)
5.5 High-Pressure Stopcocks Market
5.5.1 Overview
5.5.2 High-Pressure Stopcocks Market Revenue and Forecast to 2027 (US$ Mn)

6. Advanced Medical Stopcock Market Analysis And Forecasts To 2027 – End User
6.1 Overview
6.2 Europe Advanced Medical Stopcock Market Share By End User 2018 & 2027 (%)
6.3 Hospitals & Clinics Market
6.3.1 Overview
6.3.2 Hospitals & Clinics Market Revenue and Forecast to 2027 (US$ Mn)
6.4 Ambulatory Surgery Centers Market
6.4.1 Overview
6.4.2 Ambulatory Surgery Centers Market Revenue And Forecast To 2027 (Us$ Mn)
6.5 Homecare Market
6.5.1 Overview
6.5.2 Homecare Market Revenue And Forecast To 2027 (Us$ Mn)

7. Advanced Medical Stopcock Market Revenue And Forecasts To 2027 – Europe Analysis
7.1 Europe Advanced Medical Stopcock Market
7.1.1 Overview
7.1.2 Europe Advanced Medical Stopcock Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.3 Europe Advanced Medical Stopcock Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.1.4 Europe Advanced Medical Stopcock Market Revenue and Forecasts to 2027, By End User (US$ Mn)
7.1.5 Europe Advanced Medical Stopcock Market share, By Country (2018 & 2027) (%)
7.1.6 UK Advanced Medical Stopcock Market
7.1.6.1 UK Advanced Medical Stopcock Market Revenue And Forecasts To 2027 (US$ Mn)
7.1.6.2 UK Advanced Medical Stopcock Market Revenue And Forecasts To 2027, By Type (US$ Mn)
7.1.6.3 UK Advanced Medical Stopcock Market Revenue and Forecasts To 2027, By End User (US$ Mn)
7.1.7 Germany Advanced Medical Stopcock Market
7.1.7.1 Germany Advanced Medical Stopcock Market Revenue And Forecasts To 2027 (US$ Mn)
7.1.7.2 Germany Advanced Medical Stopcock Market Revenue And Forecasts To 2027, By Type (US$ Mn)
7.1.7.3 Germany Advanced Medical Stopcock Market Revenue and Forecasts To 2027, By End User (US$ Mn)
7.1.8 France Advanced Medical Stopcock Market
7.1.8.1 France Advanced Medical Stopcock Market Revenue And Forecasts To 2027 (US$ Mn)
7.1.8.2 France Advanced Medical Stopcock Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.8.3 France Advanced Medical Stopcock Market Revenue and Forecasts To 2027, By End User (US$ Mn)
7.1.9 Italy Advanced Medical Stopcock Market
7.1.9.1 Italy Advanced Medical Stopcock Market Revenue And Forecasts To 2027 (US$ Mn)
7.1.9.2 Italy Advanced Medical Stopcock Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.9.3 Italy Advanced Medical Stopcock Market Revenue and Forecasts To 2027, By End User (US$ Mn)
7.1.10 Spain Advanced Medical Stopcock Market
7.1.10.1 Spain Advanced Medical Stopcock Market Revenue And Forecasts To 2027 (US$ Mn)
7.1.10.2 Spain Advanced Medical Stopcock Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.10.3 Spain Advanced Medical Stopcock Market Revenue and Forecasts To 2027, By End User (US$ Mn)

8. Advanced Medical Stopcock Market –Industry Landscape
8.1 Overview
8.2 Comparative Company Analysis
8.3 Growth Strategies Done By The Companies In The Market, (%)
8.4 Organic Developments
8.4.1 Overview
8.5 Inorganic Developments
8.5.1 Overview

9. Advanced Medical Stopcock Market – Key Company Profiles
9.1 B. BRAUN MELSUNGEN AG
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Financial Overview
9.1.4 Product Portfolio
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 SMITHS MEDICAL
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Financial Overview
9.2.4 Product Portfolio
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 NIPRO
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Financial Overview
9.3.4 Product Portfolio
9.3.5 SWOT Analysis
9.3.6 Key Developments.
9.4 ELCAM MEDICAL
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Financial Overview
9.4.4 Product Portfolio
9.4.5 SWOT Analysis
9.4.6 Key Developments.
9.5 MERIT MEDICAL SYSTEMS
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Financial Overview
9.5.4 Product Portfolio
9.5.5 SWOT Analysis
9.5.6 Key Developments.
9.6 CODAN USA
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Financial Overview
9.6.4 Product Portfolio
9.6.5 SWOT Analysis
9.6.6 Key Developments.
9.7 NORDSON CORPORATION
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Financial Overview
9.7.4 Product Portfolio
9.7.5 SWOT Analysis
9.7.6 Key Developments.
9.8 COOK
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Financial Overview
9.8.4 Product Portfolio
9.8.5 SWOT Analysis
9.8.6 Key Developments.
9.9 JCM MED
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Financial Overview
9.9.4 Product Portfolio
9.9.5 SWOT Analysis
9.9.6 Key Developments.
9.10 UTAH MEDICAL PRODUCTS INC
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Financial Overview
9.10.4 Product Portfolio
9.10.5 SWOT Analysis
9.10.6 Key Developments.

10. APPENDIX
10.1 About The Publisher
10.2 GLOSSARY OF TERMS
10.3 METHODOLOGY
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • B. BRAUN MELSUNGEN AG
  • SMITHS MEDICAL
  • NIPRO
  • ELCAM MEDICAL
  • MERIT MEDICAL SYSTEMS
  • CODAN USA
  • NORDSON CORPORATION
  • COOK
  • JCM MED
  • UTAH MEDICAL PRODUCTS INC
Note: Product cover images may vary from those shown
Adroll
adroll